Campbell's cut its dividend by 35.9% as it prepares for another year of weaker sales and earnings. The cash could help reduce debt, but FY27 targets leave little room for execution missteps.
The next dividend is scheduled for November 2026, with October 1, 2026, set as the record date. Campbell's cut its quarterly payout from $0.39 to $0.25 per share, a 36% reduction. The smaller payment may free up cash to pay down debt as interest expenses rise. Shareholders who rely on that income will receive less.
The outlook is weak. Campbell's forecasts FY27 net sales to decline 2% to 4%. Adjusted EPS is expected to fall to $1.65-$1.80 from $2.17 in FY26, a projected earnings decline of 17% to 24%. Inflation and negative pricing are expected to weigh on gross margins. The forecast offers little evidence that an operating recovery is already underway.
Campbell's reported fiscal 2026 net sales of $9.74 billion, down from $10.25 billion a year earlier. Diluted EPS fell to $1.31 from $2.01.
The forecast adds another chapter to Campbell's earnings reset, covered in this earlier earnings analysis. The new outlook does not end the turnaround case. It makes the cost of waiting clearer.
Campbell's is pairing the dividend cut with a new $500 million cost-saving program, lower capital spending and continued brand investment. The company is also pursuing a broader reset, with cost cuts and plant closures discussed in coverage of its turnaround plans. Market coverage reported that operating margin fell 250 basis points to 11.3%. Inflation was a 530-basis-point headwind, partly offset by 380 basis points of cost savings. Those steps could help stabilize the business and strengthen its finances. But planned savings are not proof of execution. A separate report on Campbell's results provides more context on the reset. Consumer headwinds may constrain pricing and make it harder to protect margins.
Moody's downgraded Campbell's on weak earnings and high leverage. Market summaries put leverage at roughly 4.0x to 4.3x even after the dividend reduction, keeping debt pressure central to the turnaround case.
The investment case comes down to a trade-off, not a clean recovery story. The Buy view rests on the judgment that the current valuation already reflects substantial risk and offers an appealing long-term risk-reward. Investors who rely on dividend income have reason to reassess. The payout is smaller, and expected declines in sales and earnings leave the timing of any improvement uncertain.
A dividend cut can preserve cash for debt reduction. It does not guarantee that debt will fall or operating results will improve. Campbell's has more financial flexibility, but FY27 will put its operations to a hard test. The Buy thesis may suit investors willing to accept execution risk and lower income. Patience is required. Better returns are not promised.
